Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
Methods for catalyzing cleavage of a bond with an electric field device. In one method, a catalytic peptide having a first reactive group and a second reactive group is coupled to an electrode. The catalytic peptide is then contacted with a solution containing a substrate. The first reactive group reacts with the substrate to form a first intermediate. The second reactive group then reacts with the first intermediate to form a positively-charged second intermediate having an acyl bond and a negatively-charged first reactive group. An electronic pulsing sequence is then applied to the electrode to separate the negatively-charged first reactive group and the positively-charged second intermediate. The second intermediate is then reacted by acyl transfer to cleave the acyl bond. The first reactive group may be a sulfhydryl or deprotonated sulfhydryl. The second reactive group may be an imidazole. The substrate may contain an ester or amide bond.
This application is a continuation of application Ser. No. 10/623,080, filed Jul. 18, 2003, which is a continuation application of application Ser. No. 09/496,864, filed Feb. 2, 2000, now abandoned, which is a continuation application of application Ser. No. 08/855,058, filed May 14, 1997, entitled “Methods for Electronic Fluorescent Perturbation for Analysis and electronic Perturbation Catalysis for Synthesis,” issued as U.S. Pat. No. 6,048,690, all of which are incorporated herein by reference as if fully set forth herein.
FIELD OF THE INVENTIONThis invention relates to systems, devices, methods, and mechanisms for performing multi-step molecular biological analysis, nucleic acid hybridization reactions, nucleic acid sequencing, and the catalysis of biomolecular, organic and inorganic reactions. More particularly, the molecular biological type analysis involves electronic fluorescent perturbation mechanisms for the detection of DNA hybrids, point mutations, deletions or repeating sequences in nucleic acid hybridization reactions, electronic fluorescent perturbation mechanisms for sequencing of DNA and RNA molecules, and electric field based catalytic mechanisms for biomolecular, biopolymer and other chemical reactions.
BACKGROUND OF THE INVENTIONMolecular biology comprises a wide variety of techniques for the analysis of nucleic acid and protein. Many of these techniques and procedures form the basis of clinical diagnostic assays and tests. These techniques include nucleic acid hybridization analysis, restriction enzyme analysis, genetic sequence analysis, and the separation and purification of nucleic acids and proteins (See, e.g., J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A Laboratory Manual, 2 Ed., Cold spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989).
Most of these techniques involve carrying out numerous operations (e.g., pipetting, centrifugations, electrophoresis) on a large number of samples. They are often complex and time consuming, and generally require a high degree of accuracy. Many a technique is limited in its application by a lack of sensitivity, specificity, or reproducibility. For example, these problems have limited many diagnostic applications of nucleic acid hybridization analysis.
The complete process for carrying out a DNA hybridization analysis for a genetic or infectious disease is very involved. Broadly speaking, the complete process may be divided into a number of steps and substeps. In the case of genetic disease diagnosis, the first step involves obtaining the sample (blood or tissue). Depending on the type of sample, various pre-treatments would be carried out. The second step involves disrupting or lysing the cells, which then release the crude DNA material along with other cellular constituents. Generally, several sub-steps are necessary to remove cell debris and to purify further the crude DNA. At this point several options exist for further processing and analysis. One option involves denaturing the purified sample DNA and carrying out a direct hybridization analysis in one of many formats (dot blot, microbead, microliter plate, etc.). A second option, called Southern blot hybridization, involves cleaving the DNA with restriction enzymes, separating the DNA fragments on an electrophoretic gel, blotting to a membrane filter, and then hybridizing the blot with specific DNA probe sequences. This procedure effectively reduces the complexity of the genomic DNA sample, and thereby helps to improve the hybridization specificity and sensitivity. Unfortunately, this procedure is long and arduous. A third option is to carry out the polymerase chain reaction (PCR) or other amplification procedure. The PCR procedure amplifies (increases) the number of target DNA sequences. Amplification of target DNA helps to overcome problems related to complexity and sensitivity in genomic DNA analysis. All these procedures are time consuming, relatively complicated, and add significantly to the cost of a diagnostic test. After these sample preparation and DNA processing steps, the actual hybridization reaction is performed. Finally, detection and data analysis convert the hybridization event into an analytical result.
The steps of sample preparation and processing have typically been performed separate and apart from the other main steps of hybridization and detection and analysis. Indeed, the various substeps comprising sample preparation and DNA processing have often been performed as a discrete operation separate and apart from the other substeps. Considering these substeps in more detail, samples have been obtained through any number of means, such as obtaining of full blood, tissue, or other biological fluid samples. In the case of blood, the sample is processed to remove red blood cells and retain the desired nucleated (white) cells. This process is usually carried out by density gradient centrifugation. Cell disruption or lysis is then carried out, preferably by the technique of sonication, freeze/thawing, or by addition of lysing reagents. Crude DNA is then separated from the cellular debris by a centrifugation step. Prior to hybridization, double-stranded DNA is denatured into single-stranded form. Denaturation of the double-stranded DNA has generally been performed by the techniques involving heating (>Tm), changing salt concentration, addition of base (NaOH), or denaturing reagents (urea, formamide, etc.). Workers have suggested denaturing DNA into its single-stranded form in an electrochemical cell. The theory is stated to be that there is electron transfer to the DNA at the interface of an electrode, which effectively weakens the double-stranded structure and results in separation of the strands. See, generally, Stanley, “DNA Denaturation by an Electric Potential”, U.K. patent application 2,247,889 published Mar. 18, 1992.
Nucleic acid hybridization analysis generally involves the detection of a very small number of specific target nucleic acids (DNA or RNA) with an excess of probe DNA, among a relatively large amount of complex non-target nucleic acids. The substeps of DNA complexity reduction in sample preparation have been utilized to help detect low copy numbers (i.e. 10,000 to 100,000) of nucleic acid targets. DNA complexity is overcome to some degree by amplification of target nucleic acid sequences using polymerase chain reaction (PCR). (See, M. A. Innis et al, PCR Protocols: A Guide to Methods and Applications, Academic Press, 1990). While amplification results in an enormous number of target nucleic acid sequences that improves the subsequent direct probe hybridization step, amplification involves lengthy and cumbersome procedures that typically must be performed on a stand alone basis relative to the other substeps. Substantially complicated and relatively large equipment is required to perform the amplification step.
The actual hybridization reaction represents the most important and central step in the whole process. The hybridization step involves placing the prepared DNA sample in contact with a specific reporter probe, at a set of optimal conditions for hybridization to occur to the target DNA sequence. Hybridization may be performed in any one of a number of formats. For example, multiple sample nucleic acid hybridization analysis has been conducted on a variety of filter and solid support formats (See G. A. Beltz et al., in Methods in Enzymology, Vol. 100, Part B, R. Wu, L. Grossman, K. Moldave, Eds., Academic Press, New York, Chapter 19, pp. 266-308, 1985). One format, the so-called “dot blot” hybridization, involves the non-covalent attachment of target DNAs to filter, which are subsequently hybridized with a radioisotope labeled probe(s). “Dot blot” hybridization gained wide-spread use, and many versions were developed (see M. L. M. Anderson and B. D. Young, in Nucleic Acid Hybridization—A Practical Approach, B. D. Hames and S. J. Higgins, Eds., IRL Press, Washington, D.C. Chapter 4, pp. 73-111, 1985). It has been developed for multiple analysis of genomic mutations (D. Nanibhushan and D. Rabin, in EPA 0228075, Jul. 8, 1987) and for the detection of overlapping clones and the construction of genomic maps (G. A. Evans, in U.S. Pat. No. 5,219,726, Jun. 15, 1993).
New techniques are being developed for carrying out multiple sample nucleic acid hybridization analysis on micro-formatted multiplex or matrix devices (e.g., DNA chips) (see M. Barinaga, 253 Science, pp. 1489, 1991; W. Bains, 10 Bio/Technology, pp. 757-758, 1992). These methods usually attach specific DNA sequences to very small specific areas of a solid support, such as micro-wells of a DNA chip. These hybridization formats are micro-scale versions of the conventional “dot blot” and “sandwich” hybridization systems.
The micro-formatted hybridization can be used to carry out “sequencing by hybridization” (SBH) (see M. Barinaga, 253 Science, pp. 1489, 1991; W. Bains, 10 Bio/Technology, pp. 757-758, 1992). SBH makes use of all possible n-nucleotide oligomers (n-mers) to identify n-mers in an unknown DNA sample, which are subsequently aligned by algorithm analysis to produce the DNA sequence (R. Drmanac and R. Crkvenjakov, Yugoslav Patent Application No. 570/87, 1987; R. Drmanac et al., 4 Genomics, 114, 1989; Strezoska et al., 88 Proc. Natl. Acad. Sci. USA 10089, 1992; and R. Dramanac and R. B. Crkvenjakov, U.S. Pat. No. 5,202,231, Apr. 13, 1993).
There are two formats for carrying out SBH. The first format involves creating an array of all possible n-mers on a support, which is then hybridized with the target sequence. The second format involves attaching the target sequence to a support, which is sequentially probed with all possible n-mers. Both formats have the fundamental problems of direct probe hybridizations and additional difficulties related to multiplex hybridizations.
Southern, United Kingdom Patent Application GB 8810400, 1988; E. M. Southern et al., 13 Genomics 1008, 1992, proposed using the first format to analyze or sequence DNA. Southern identified a known single point mutation using PCR amplified genomic DNA. Southern also described a method for synthesizing an array of oligonucleotides on a solid support for SBH. However, Southern did not address how to achieve optimal stringency condition for each oligonucleotide on an array.
Concurrently, Drmanac et al., 260 Science 1649-1652, 1993, used the second format to sequence several short (116 bp) DNA sequences. Target DNAs were attached to membrane supports (“dot blot” format). Each filter was sequentially hybridized with 272 labeled 10-mer and 11-mer oligonucleotides. A wide range of stringency condition was used to achieve specific hybridization for each n-mer probe; washing times varied from 5 minutes to overnight, and temperatures from 0° C. to 16° C. Most probes required 3 hours of washing at 16° C. The filters had to be exposed for 2 to 18 hours in order to detect hybridization signals. The overall false positive hybridization rate was 5% in spite of the simple target sequences, the reduced set of oligomer probes, and the use of the most stringent conditions available.
A variety of methods exist for detection and analysis of the hybridization events. Depending on the reporter group (fluorophore, enzyme, radioisotope, etc.) used to label the DNA probe, detection and analysis are carried out fluorometrically, calorimetrically, or by autoradiography. By observing and measuring emitted radiation, such as fluorescent radiation or particle emission, information may be obtained about the hybridization events. Even when detection methods have very high intrinsic sensitivity, detection of hybridization events is difficult because of the background presence of non-specifically bound materials.
In the many applications of DNA hybridization for research and diagnostics, the most difficult analysis involve the differentiation of a single base mismatch from a match target sequence. This is because the analysis involves discriminating a small difference in one hybridized pair, the mismatch, from the match. The teachings of this invention are of particular relevance to these problems.
SUMMARY OF THE INVENTIONAs a main aspect of this invention, it has been surprisingly discovered that the fluorescence signal obtained during the electronic denaturation or dehybridization of DNA hybrids is perturbed at or around the electronic power (current and voltage) levels which are associated with the denaturation or dehybridization process. In one embodiment, the fluorescence signal perturbation phenomena appears as a rise or spike in fluorescence intensity prior to dehybridization of a fluorescent labeled probe from a capture sequence attached to the microlocation test site. The power level, amplitude and slope of this fluorescence spike provide analytical tools for diagnosis. The combination of the fluorescence perturbation with other measurements also indicative of the hybridization match/mismatch state, such as consideration of the electronic melting (50% fluorescence decrease during electronic stringency control) can in combination provide a more efficient and reliable hybridization match/mismatch analysis.
In general, this controlled dehybridization or electronic stringency process results in a significant differential between the final fluorescent intensity values for the match versus the mismatch sequence. This difference in fluorescent intensity values is used to determine a discrimination ratio, which confirms and identifies that a particular mismatch was present in the sample.
It has been discovered that the fluorescent perturbation effect (FPE) provides a powerful analytical tool for DNA hybridization analysis, particularly for the near instantaneous, e.g., less than one minute, and especially less than 5 seconds, discrimination of match/mismatched DNA hybrids. Novel DNA sequencing applications are possible. New fluorescent donor/acceptor/quencher energy transfer mechanisms are created. New electronic catalytic mechanisms are created.
In one aspect, this invention relates to using precisely controlled electric or electrophoretic fields to cause or influence fluorophore or chromophore groups in special arrangements with molecular structures (such as nucleic acids), to produce rapid signal variations (perturbations) which correlate with and identify small differences in these molecular structures. In a preferred method for hybridization analysis of a sample, an electronic stringency control device is used to perform the steps of: providing the sample, a first probe with a fluorescent label and a second probe with a label under hybridization conditions on the electronic stringency control device, forming a hybridization product, subjecting the hybridization product to an electric field force, monitoring the fluorescence from the hybridization product, and analyzing the fluorescent signal. The label preferably serves as a quencher for the fluorescent label.
Most broadly, this invention relates to integrated microelectronic systems, devices, components, electronic based procedures, electronic based methods, electronic based mechanisms, and flurophore/chromophore arrangements for: (1) molecular biological and clinical diagnostic analyses; (2) nucleic acid sequencing applications; and (3) for carrying out catalysis of biomolecular, organic, and inorganic reactions.
More specifically, the molecular biological and clinical diagnostic analyses relate to the utilization of the electronic fluorescent perturbation based mechanisms for the detection and identification of nucleic acid hybrids, single base mismatches, point mutations, single nucleotide polymorphisms (SNPs), base deletions, base insertions, crossover/splicing points (translocations), intron/exon junctions, restriction fragment length polymorphisms (RFLPs), short tandem repeats (STRs) and other repeating or polymorphic sequences in nucleic acids.
More specifically, the nucleic acid sequencing applications involve utilization of the electronic fluorescent perturbation based mechanisms to elucidate base sequence information in DNA, RNA and in nucleic acid derivatives. Most particularly, to elucidate sequence information from the terminal ends of the nucleic acid molecules. This method achieves electronic fluorescence perturbation on an electronic stringency control device comprising the steps of: locating a first polynucleotide and a second polynucleotide adjacent the electronic stringency control device, the first polynucleotide and second polynucleotide being complementary over at least a portion of their lengths and forming a hybridization product, the hybridization product having an associated environmental sensitive emission label, subjecting the hybridization product and label to a varying electrophoretic force, monitoring the emission from the label, and analyzing the monitored emission to determine the electronic fluorescence perturbation effect.
More specifically, the catalytic reactions relate to the utilization of electronic based catalytic mechanisms for carrying out biomolecular, biopolymer, organic polymer, inorganic polymer, organic, inorganic, and other types of chemical reactions. Additionally, the electronic based catalytic mechanisms can be utilized for carrying out nanofabrication, and other self-assembly or self-organizational processes. This method provides for electronic perturbation catalysis of substrate molecules on an electronic control device containing at least one microlocation comprising the steps of: immobilizing on the microlocation an arrangement of one or more reactive groups, exposing the reactive groups to a solution containing the substrate molecules of interest, and applying an electronic pulsing sequence which causes charge separation between the reactive groups to produce a catalytic reaction on the substrate molecules.
More generally, the present invention relates to the design, fabrication, and uses of self-addressable self-assembling microelectronic integrated systems, devices, and components which utilize the electronic mechanisms for carrying out the controlled multi-step processing and multiplex reactions in a microscopic, semi-microscopic and macroscopic formats. These reactions include, but are not limited to, most molecular biological procedures, such as: (1) multiplex nucleic acid hybridization analysis in reverse dot blot formats, sandwich formats, homogeneous/heterogeneous formats, target/probe formats, in-situ formats, and flow cytometry formats; (2) nucleic acid, DNA, and RNA sequencing; (3) molecular biological restriction reactions, ligation reactions, and amplification type reactions; (4) immunodiagnostic and antibody/antigen reactions; (5) cell typing and separation procedures; and (6) enzymatic and clinical chemistry type reactions and assays.
In addition, the integrated systems, devices, and components which utilize electronic based catalytic mechanisms are able to carry out biomolecular, biopolymer and other types of chemical reactions: (1) based on electric field catalysis; and/or (2) based on multi-step combinatorial biopolymer synthesis, including, but not limited to, the synthesis of polynucleotides and oligonucleotides, peptides, organic molecules, bio-polymers, organic polymers, mixed biopolymers/organic polymers, two and three dimensional nanostructures, and nanostructures and micron-scale structures on or within silicon or other substrate materials.
Additionally, with respect to electronic fluorescent perturbation mechanisms, the present invention relates to unique intermolecular and intramolecular constructs and arrangements of chromophores, fluorophores, luminescent molecules or moities, metal chelates (complexes), enzymes, peptides, and amino acids, associated with nucleic acid sequences, polypeptide sequences, and/or other polymeric materials. Of particular importance being those constructs and arrangements of fluorophores and chromophores which produce fluorescent energy transfer, charge transfer or mechanical mechanisms which can be modulated or affected by electric or electrophoretic fields to produce fluorescent or luminescent signals which provide information about molecular structure.
With respect to the electronic catalytic mechanisms in homogeneous (solution) or heterogeneous (solution/solid support) formats, the present invention relates to unique intermolecular and intramolecular constructs and arrangements of chromophores, fluorophores, luminescent molecules or moities, metal chelates (complexes), enzymes, peptides, and amino acids, nucleophilic molecules or moities, electrophilic molecules or moities, general acid or base catalytic molecules or moieties, and substrate binding site molecules and moities, associated with nucleic acid sequences, polypeptide sequences, other biopolymers, organic polymers, inorganic polymers, and other polymeric materials.
Additionally, this invention relates to the utilization of electric or electrophoretic fields to induce fluorescent perturbation based mechanisms in arrangements of fluorophores and chromophores in solid state or sol-gel state optoelectronic devices and optical memory materials.
It is therefore an object of this invention to provide for methods and systems for improved detection and analysis of biological materials.
It is yet a further object of this invention to provide for methods which provide for the rapid and accurate discrimination between matches and mismatches in nucleic acid hybrids.
BRIEF DESCRIPTION OF THE DRAWINGS
The APEX device as described in the various parent applications has been utilized in novel ways resulting in methods which improve the analytical or diagnostic capabilities of the device. It has been surprisingly discovered that the fluorescent signal is perturbed during the electronic dehybridization of DNA hybrids. This method has particular application to DNA hybridization and single-base mismatch analysis. Specifically, during electronic dehybridization, also known as stringency control or electronic stringency control, a rise or spike in the fluorescence intensity has been observed just prior to the dehybridization of the fluorescent labeled probes from capture sequences attached to the APEX chip pad.
Electronic denaturation was then carried out by biasing the test pad negative, and increasing the power to the test pad from ˜10−1 microwatts (μW) to ˜2×102 microwatts (μW) over a 90 second time period. Three pads were tested for each of the target probes. The relative change in fluorescent intensity was plotted as a function of the increasing power. In general, the electrophoretic field, force or power necessary to dehybridize a probe from its complementary sequence correlates with the binding energy or Tm (melting temperature) for the DNA duplex. In above experiments the overall power level (μW) necessary to dehybridize the 19-mer probe with 53% GC probe (Tm of 54° C.) was higher than for the 20-mer probe with 100% AT (Tm of 33° C.), that is, the equivalent electronic melting point (Em) at which dehybridization is 50% complete is higher for the 53% GC probe. Also, the fluorescent perturbation (
The fluorescent perturbation phenomena correlates well with the sequence specificity of the dehybridization process. The power level (μW) value, amplitude and slope of the fluorescent spike are useful for many aspects of hybridization analysis including single base mismatch analysis. The fluorescent perturbation (Fp) value, namely those values associated with the fluorescence perturbation, e.g., onset value, peak height and slope, combined with the electronic melting (Em) values, namely, the half-height value of fluorescence, provide significantly higher reliability and additional certainty to hybridization match/mismatch analysis. By combining two or more analytical measurements, a more effective and precise determination may be made.
In the above experiments, the target probes were labeled with a Bodipy Texas Red fluorophore in their 5′ terminal positions. While Bodipy TR is not a particularly environmentally sensitive fluorophore it nevertheless showed pronounced effects during electronic denaturation. More environmentally sensitive fluorophores may be used to obtain larger perturbations in their fluorescent properties during electronic dehybridization.
The placement of a sensitive fluorescent label in optimal proximity to the initial denaturation site is preferred. By associating certain fluorescent labels in proximity to the denaturation site, as opposed to labeling at the end of the target or probe, increased specificity and enhanced effects may result. As shown in
Furthermore, the use of a mismatch site directed fluorophore label does not require that the hybrid be completely denatured during the process. As shown in
Referring to
The fluorescent perturbation effect (FPE) is usually most pronounced for a one base mismatched probe sequence relative to the match probe sequence. In the general electronic hybridization and dehybridization procedure, the precisely controlled electronic stringency process results in a significant differential between the final fluorescent intensity values for the match versus the mismatch sequence. The mismatch sequence is more effectively dehybridized and more rapidly removed from the test location than the match sequence. In the general electronic hybridization and dehybridization process this difference in fluorescent intensity values is used to determine a discrimination ratio, which confirms and identifies that a particular mismatch was present in the sample. The particular parameters of electric field strength (current/voltage), solution conductivity, electrode geometry and pulsing time used to produce this selective dehybridization between the match and the mismatch occur at what is called the electronic melting temperature (Etm). The electronic dehybridization and stringency process allows match/mismatch discriminations to be carried out very rapidly (within substantially 20 to 60 seconds), compared with the classical hybridization stringency process, which involves temperature control and stringent washing procedures, which can take hours to complete. The single base pair mismatch (single BPM) sequence is observed to decrease faster than the match sequence allowing one to obtain a match/mismatch discrimination ratio for the pair.
Initial observations of the fluorescent perturbation effect (FPE), which occurs almost immediately upon initiation of the electronic dehybridization process, indicated that it was possible to use the FPE as a way to distinguish match/mismatched DNA hybrids even more rapidly, typically in less than a minute, and most preferably in several seconds or less. Another very powerful and novel feature of the FPE is that this technique does not require the removal of the probe or target sequence in order to discriminate a match from the mismatch hybrid, whereas the general electronic dehybridization process and classical hybridization techniques typically require the removal of the mismatch sequence relative to the matched sequence. A further advantage of the FPE technique is that probes of any size can potentially be used for match/mismatch hybrid discriminations or other applications. Longer probes sequences can provide overall better hybridization stability and selectivity.
Further investigations of the fluorescent perturbation effect has revealed other aspects and advantages of this unique phenomena which include: (1) that the amplitude, frequency, and slope of this fluorescent signal can provide a powerful analytical tool for other types of DNA hybridization analysis, in addition to the near instantaneous discrimination of single base mismatched DNA; (2) that multiple probe systems, involving a quencher probe and fluorescent acceptor probe (and donor probes), can be used to further enhance the FPE technique; (3) that a variety of electronic pulsing sequences (DC and AC variations) can be developed which further improve and broaden the scope of FPE based analysis of DNA and other molecular structures; (4) that the electronic fluorescence perturbation mechanism could lead to DNA sequencing applications; (5) that new arrangements of fluorescent donor/acceptor/quencher groups could be created for improved energy transfer mechanisms and applications; and (6) that novel electronic catalytic mechanisms could be created. These are the subjects of this invention.
The basic fluorescent perturbation effect occurs generally upon the initiation of electronic denaturation of match and mismatch hybrid pairs. In the case of the Ras (ras oncogene) hybrids in
It is believed that the subtle fluorophore/DNA structural interactions are also very important. This is the basis for DNA sequencing techniques disclosed herein.
In general electronic hybridization and stringency experiments, the reporter or target probes are typically labeled with a Bodipy Texas Red fluorophore in their 5′ (or 3′) terminal positions. While Bodipy TR is not a particularly environmentally sensitive fluorophore it nevertheless showed pronounced effects during electronic dehybridization process. More environmentally sensitive fluorophores may be used to obtain larger perturbations in their fluorescent properties during FPE process. By way of example, these fluorophores and chromophores include: other Bodipy dye derivatives, ethidiums (in particular derivatized forms of ethidium dyes which can be covalently attached to DNA), or other intercalating fluorophores (which are or can be derivatized for attachment to DNA, acridines, fluoresceins, rhodoamines, Texas Red (sulforhodamine 101), Cy3 and Cy5 dyes, Lucifer Yellow, and Europium and Terbium chelate dye derivatives, IR144 and far red laser dyes and derivatives. Other fluorophores, chromophores and dyes consistent with the methods and objects of these inventions may be utilized.
In general, any dye which is sensitive to the environmental parameters such as hydrophilicity, hydrophobicity, pH, electrostatic charge, Van der Waals interactions, etc., that can cause changes in the fluorescent intensity (quantum yield), the excitation/emission spectrum, and/or the fluorescent life time, are potentially useful for FPE applications. More particularly useful, are those fluorophores, chromophores, or dyes which have properties which change or are perturbed due to the following.
(1) The initial disruption or destabilization of the double-stranded DNA structure. This is optionally just near the terminal position of the DNA structure where the fluorophore is located.
(2) The effects of the DC or AC electric field (or electrophoretic field) on the fluorophore itself. Of importance would be whether the fluorophore is neutral or charged, and whether the net charge is positive or negative. The net charge could strongly influence the perturbation effect, particularly if the fluorophore were positively charged. In this case, the fluorophore would tend to move in an opposite direction relative to the rest of the DNA molecule when an electric field is applied.
(3) The effect of the DC or AC electric field (or electrophoretic field) on the fluorophore/DNA interaction itself. Again, whether the fluorophore was neutral, net positive, or net negatively charged would have a pronounced effect on the nature and stability of the fluorophore/DNA interaction.
(4) The general spectral properties and robustness of the dye are also important. For example, the excitation and emission maxima, the Stokes shift, and the resistance to fading under excitation conditions are also important. Of particular usefulness would be those dyes which have excitation maxima at or above 480 nm, and emissions at or above 520 nm, and Stokes shifts of more than 20 nm. More useful, would be those dyes which have excitation maxima at or above 590 nm, and emissions at or above 620 nm, and Stokes shifts of more than 20 nm. Most useful, would be those dyes which have excitation maximum at or above 650 nm, and emissions at or above 670 nm, and Stokes shifts of more than 20 nm.
The placement of a sensitive fluorophore or chromophore label or reporter in optimal proximity to the initial destabilization or base mismatch site is important for achieving the electronic fluorescent perturbation effect (FPE). The preferred arrangements would be to have the fluorophore or chromophore within 0 to 10 bases of the initial destabilization or base mismatch site. The most preferred arrangements would be to have the fluorophore or chromophore within 0 to 5 bases of the initial destabilization or base mismatch site.
It should be kept in mind, that when a fluorophore or chromophore group is at the terminal position (5′ or 3′) of a DNA sequence which is hybridized to a complementary sequence, the group is already located in some sense at a “destabilized” site relative to the rest of the hybridized structure. This is because the terminal or end positions of a hybrid structure are less stable (the strands are opening and closing or fraying) relative to the internal hybridized sequence. One important aspect of this invention is to design the probe sequences such that they now position the further destabilizing base mismatch nucleotide site (in the target or probe sequence), so that upon hybridization the base mismatch is in closer proximity to the terminal fluorophore or chromophore group or groups. By associating the destabilization site in closer proximity to the terminal fluorophore or chromophore group(s), it is possible to utilize electronic pulsing sequences which produce fluorescent perturbation effects which correlate well with molecular structure, i.e., detect and identify point mutations, base deletions, base insertion, nucleotide repeat units, and other features important to DNA analysis.
Additional advantages to the FPE technique include: (1) the ability to utilize longer probes (>20-mer) than those used in conventional hybridization procedures, (2) that probe specificity can be determined by placement of the fluorophore or chromophore label (particularly for single base mismatches), and (3) FPE technique does not require dehybridization or removal of the mismatched probe sequence from the system; therefore, each sample can be analyzed repetitively providing a higher statistical significant to data, such as through signal averaging techniques.
Most particularly, this invention relates to using precisely controlled AC or DC electric fields or electrophoretic fields to affect or influence fluorophore or chromophore groups in special arrangements with molecular structures (such as nucleic acids), to produce rapid signal variations (perturbations) which correlate with and identify small differences in these molecular structures.
Most broadly, this invention relates to integrated microelectronic systems, devices, components, electronic based procedures, electronic based methods, electronic base mechanisms, and fluorophore/chromophore arrangements for: (1) molecular biological and clinical diagnostic analyses; (2) nucleic acid sequencing applications; and (3) for carrying out catalysis of biomolecular, organic, and inorganic reactions.
More specifically, the molecular biological and clinical diagnostic analyses relate to the utilization of the electronic fluorescent perturbation based mechanisms for the detection and identification of nucleic acid hybrids, single base mismatches, point mutations, single nucleotide polymorphisms (SNPs), base deletions, base insertions, crossover/splicing points (translocations), intron/exon junctions, restriction fragment length polymorphisms (RFLPs), short tandem repeats (STRs) and other repeating or polymorphic sequences in nucleic acid acids.
More specifically, the nucleic acid sequencing applications involve utilization of the electronic fluorescent perturbation based mechanisms to elucidate base sequence information in DNA, RNA, and in nucleic acid derivatives. Most particularly, to elucidate sequence information from the terminal ends of the nucleic acid molecules.
More specifically, the catalytic reactions relate to the utilization of electronic based catalytic mechanisms for carrying out biomolecular, biopolymer, organic polymer, inorganic polymer, organic, inorganic, and other types of chemical reactions. Additionally, the electronic based catalytic mechanisms can be utilized for carrying out nanofabrication, and other self-assembly or self-organizational processes. More generally, the present invention relates to the design, fabrication, and uses of self-addressable self-assembling microelectronic integrated systems, devices, and components which utilize the electronic mechanisms for carrying out the controlled multi-step processing and multiplex reactions in a microscopic, semi-microscopic and macroscopic formats. These reactions include, but are not limited to, most molecular biological procedures, such as: (1) multiplex nucleic acid hybridization analysis in reverse dot blot formats, sandwich formats, homogeneous/heterogeneous formats, target/probe formats, and in-situ formats, and flow cytometry formats; (2) nucleic acid, DNA, and RNA sequencing; (3) molecular biological restriction reactions, ligation reactions, and amplification type reactions; (4) immunodiagnostic and antibody/antigen reactions; (5) cell typing and separation procedures; and (6) enzymatic and clinical chemistry type reactions and assays.
In addition, the integrated systems, devices, and components which utilize electronic based catalytic mechanisms are able to carry out biomolecular, biopolymer and other types of chemical reactions: (1) based on electric field catalysis; and/or (2) based on multi-step combinatorial biopolymer synthesis, including, but not limited to, the synthesis of polynucleotides and oligonucleotides, peptides, organic molecules, biopolymers, organic polymers, mixed biopolymers/organic polymers, two and three dimensional nanostructures, and nanostructures and micron-scale structures on or within silicon or other substrate materials.
Additionally, with respect to electronic fluorescent perturbation mechanisms, the present invention relates to unique intermolecular and intramolecular constructs and arrangements of chromophores, fluorophores, luminescent molecules or moities, metal chelates (complexes), enzymes, peptides, and amino acids, associated with nucleic acid sequences, polypeptide sequences, and/or other polymeric materials. Of particular importance being those constructs and arrangements of fluorphores and chromophores which produce fluorescent energy transfer, charge transfer or mechanical mechanisms which can be modulated or affected by the AC or DC electric fields or electrophoretic fields to produce fluorescent or luminescent signals which provide information about molecular structure.
With respect to the electronic catalytic mechanisms in homogeneous (solution) or heterogeneous (solution/solid support) formats, the present invention relates to unique intermolecular and intramolecular constructs and arrangements of chromophores, fluorophores, luminescent molecules or moities, metal chelates (complexes), enzymes, peptides, and amino acids, nucleophilic molecules or moities, electrophilic molecules or moities, general acid or base calalytic molecules or moieties, and substrate binding site molecules and moities, associated with nucleic acid sequences, polypeptide sequences, other biopolymers, organic polymers, inorganic polymers, and other polymeric materials.
Additionally, this invention relates to the utilization of electric or electrophoretic fields to induce fluorescent perturbation based mechanisms in arrangements of fluorophores and chromophores in solid state or sol-gel state optoelectronic devices and optical memory materials.
FPE with a Single Fluorophore
FPE with Multiple Fluorophore/Chromophore Arrangements
In the example shown in
Of particular usefulness for this invention is one of the preferred arrangement shown in
Additionally, the scope of this invention includes the use and incorporation of various donor/acceptor/quencher, mechanisms, probe arrangements and hybridization formats which were described in our photonic patents (U.S. Pat. No. 5,532,129 and U.S. Pat. No. 5,565,322) and optical memory application (WO 95/34890). The novel electronic pulsing scenarios combined with the donor/acceptor/quencher arrangements described in the above applications leads to useful FPE quenching and energy transfer mechanism, which further enhance and expand the usefulness of the techniques for DNA hybridization and other molecular analysis.
Electronic Perturbation Catalysis
The discovery of the fluorescent perturbation effect has also contributed to the further discovery of a way to carry out novel electronic perturbation catalysis. In particular it lead to discovering a way to over come what is called the leaving group effect in enzyme catalysis. Investigators trying to create synthetic enzyme-like catalysts have not been able to overcome this obstacle. (see M. J. Heller, J. A. Walder, and I. M. Klotz, Intramolecular Catalysis of Acylation and Deacylation in Peptides Containing Cysteine and Histidine, J. American Chemical Society, 99, 2780, 1997).
Experimental Results
EXAMPLE 1 Ras G Match/MismatchAPEX Chip Preparation and Capture Probe Loading—APEX active DNA chips, with 25 microlocation test sites (80 microns in diameter) were coated with streptavidin agarose accordingly. A 2.5% glyoxal agarose (FMC) solution in water was made according to manufacturer's instructions. The stock was equilibrated at 65° C., for 5 minutes. Chips were spin coated at 2.5K rpm for 20 seconds. Another layer was then applied at 10K rpm for 20 seconds. This second “thin layer was composed of a 1:4 mix of 5 mg/ml streptavidin (BM) in 50 mM NaPhosphate, 250 mM NaCl and 2.5% glyoxal agarose.
The chips were baked at 37° C. for 30 minutes. Streptavidin was coupled to the agarose via Schiff's base reduction in 0.1M NaCNBH3 in 0.3M NaBorate, pH 9.0, for 60 minutes, at room temperature. The remaining aldehydes were capped with 0.1M glycine, for 30 minutes, at room temperature, and finally rinsed in water, dried under N2 and then stored at 4° C.
The table below gives the sequence and labeling positions for all the oligonucleotide probes and target sequences used in examples 1 and 2. Mismatches are underlined and bolded.
Capture Probe Addressing for Example 1—Columns 1 & 2 on the APEX chip were electronically addressed with the Ras 415 (match) sequence and columns 4 & 5 loaded with Ras 416 (mismatch) sequence. Addressing was carried out in 50 mM cysteine, 1□M oligonucleotide, 200 nA for 1 min. The target/reporter sequence Ras 411 was passively hybridized in 500 mM NaCl, 50 mM NaPhosphate pH 7.4, at room temperature for 5 minutes). Electronic dehybridization and stringency was done at 1.5 μA/microlocation, DC pulsing for 0.1 sec on, 0.2 sec off, 150 cycles (20 mM NaPhosphate, pH 7.4). Microlocations were given electronic stringency individually. Fluorescence signal was captured at 1 second intervals. Normalized displayed is the average of three test sites for each point. Error bars are standard deviations. Results are shown in
The APEX chip preparation procedure was the same as Example 1. Capture probe addressing conditions were the same as Example 1. The Ras 415 sequence was electronically addressed to all 5 microlocations in column 1 and Ras 416 addressed to all 5 microlocations in column 2 of the APEX chip. The HLA 241 sequence was addressed to all 5 microlocations in column 4 and HLA 378 was addressed to all 5 microlocations in column 5. The Ras 411 and HLA 253 fluorescent target probes were mixed and passively hybridized to the APEX chip. Electronic dehybridization and stringency was carried out for the Ras system at 1.5 μA/microlocation, DC pulsing for 0.1 sec on, 0.2 sec off, 150 cycles (20 mM NaPhosphate, pH 7.4). Electronic dehybridization and stringency for the HLA system was carried out at 0.6 μA/microlocation, DC pulsing for 0.1 sec on, 0.2 sec off, 150 cycles (20 mM NaPhosphate, pH 7.4). Data collected as reported above.
APEX Chip Preparation and Capture Probe Loading—APEX active DNA chips, with 25 microlocation test sites (80 microns in diameter) were coated with streptavidin agarose accordingly. A 2.5% glyoxal agarose (FMC) solution in water was made according to manufacturer's instructions. The stock was equilibrated at 65° C., for 5 minutes. Chips were spin coated at 2.5K rpm for 20 seconds. Another layer was then applied at 10K rpm for 20 seconds. This second “thin layer was composed of a 1:4 mix of mg/ml streptavidin (BM) in 50 mM NaPhosphate, 250 mM NaCl and 2.5% glyoxal agarose. The chips were baked at 37° C. for 30 minutes. Streptavidin was coupled to the agarose via Schiff's base reduction in 0.1M NaCNBH3 in 0.3M NaBorate, pH 9.0, for 60 minutes, at room temperature. The remaining aldehydes were capped with 0.1M glycine, for 30 minutes, at room temperature, and finally rinsed in water, dried under N2 and then stored at 4° C.
The sequences for the oligonucleotide reporter probe, quencher probe and capture probe used in Examples 3 and 4 are listed below:
The capture probes were addressed to specific microlocation test sites (pads) on the APEX chip as follows: a 10 μl aliquot containing 500 nM capture probe in 50 mM histidine buffer was applied to the chip and positive bias was applied at 200 nA/pad, for 30 seconds. The bias was turned off and the chip was fluidically washed in 50 mM histidine. QATAR-1 was addressed to column 1, QATAR-3A was addressed to column 2, QATAR-4A was addressed to column 3, and QATAR-5 was addressed to column 4.
Hybridization and Quenching Efficiency
The addressed APEX chips were passively hybridized with ET60-BTR reporter with/without ET71-MG quencher at 500 nM each in 100 mM NaPhosphate, at pH 7.2, 250 mM NaCl, at 65° C. in a heat block, for 2 minutes. The chips were washed in 20 mM NaPhosphate, pH 7.2, at room temperature, 3 times for 10 minutes each wash.
Comparison of hybridization signal intensities indicated that fluorescent quenching was about 50% efficient. This could be improved with optimized spacing and or increased purification of the probes (higher specific activity).
Fluorescence Perturbation for Reporter Probe Only
The chips were mounted on a probe station with a probe card to provide electrical contact to the chip, waveforms were supplied by Keithley Power Supply, images acquired via Optronics cooled color CCD and NIH image software was used to analyze the data. The preferred imaging system is that disclosed in copending U.S. application entitled “Scanning Optical Detection System”, filed May 1, 1997, incorporated herein by reference as if fully set forth herein.
Chips were prepared and hybridized as described in Example 1 and 2. In 20 mM NaPhosophate, pH 7.2, individual pads were biased negative and a pulse waveform was applied. Parameters tested were pulse frequency, % duty cycle, and amplitude. Good fluorescence perturbation results were observed at 600 nA/1 sec On/1.5 sec Off. The camera integration was 1.0 second. Higher pulse frequencies could also be effective but these experiments were limited by the amount of fluorescence at each pad location which necessitated longer camera integration times.
Results from the perfect match reporter/quencher pair on QATAR 1 showed approx 10% increase in fluorescence intensity when the power was first applied and the intensity oscillated during the course of the waveform. On QATAR-5 which did not have the quencher hybridized there was very little fluorescence perturbation. Both QATAR 3a and 4a some fluorescence perturbation but not as much as QATAR1. Additionally, signal loss after bias was greatest for QATAR-4A, followed by 3A, followed by 5 and then 1. This would be expected based on the hybrid Tm's. The results for QATAR-1 (match) and the QATAR-3 (mismatch) are shown in
APEX chips were prepared and hybridized as described in Examples 1, 2, and 3. Microlocation test sites were biased as in Example 3 except that the CCD camera integration was 0.5 seconds. Results showed that QATAR-1 produced approximately 60% increase in fluorescence intensity when power first applied and intensity oscillated during the entire waveform. For QATAR-5, which did not have the quencher when hybridized, there was very little fluorescence perturbation. Both QATAR 3A and 4A showed an initial increase in fluorescence approaching 40%. There was a significant decrease in intensity on QATAR-4A after bias applied. This is indicative of the lower Tm of this hybrid which had 2 mismatches. The results for QATAR 1 (match) and QATAR 3 (mismatch) are shown in
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it may be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Claims
1. A method for catalyzing a cleavage of a bond with an electric field device, comprising the steps of:
- coupling a catalytic peptide sequence to an electrode, wherein the catalytic peptide sequence has a first reactive group and a second reactive group;
- contacting the catalytic peptide sequence that is coupled to the electrode with a solution containing a substrate to be hydrolyzed;
- reacting the first reactive group with the substrate to form a first intermediate;
- reacting the second reactive group with the first intermediate to form a positively charged second intermediate and a negatively charged first reactive group, wherein the positively charged second intermediate comprises an acyl bond;
- applying an electronic pulsing sequence to the electrode to separate the negatively charged first reactive group from the positively charged second intermediate; and
- reacting the second intermediate by acyl transfer to cleave the acyl bond.
2. The method of claim 1, wherein the first reactive group is a sulfhydryl.
3. The method of claim 1, wherein the first reactive group is a deprotonated sulfhydryl group.
4. The method of claim 3, wherein the deprotonated sulfhydryl group is formed from a de-protonated cysteine.
5. The method of claim 1, wherein the second reactive group is an imidazole.
6. The method of claim 5, wherein the imidazole is part of a histidine.
7. The method of claim 1, wherein the acyl bond is an amide.
8. The method of claim 1, wherein the catalytic peptide is coupled to a permeation layer associated with the electrode.
9. The method of claim 1, wherein the substrate comprises an ester.
10. The method of claim 1, wherein the substrate comprises an amide.
11. The method of claim 1, wherein the step of reacting the second intermediate by acyl transfer to cleave the acyl bond comprises hydrolyzing the acyl bond.
12. A method for catalyzing cleavage of a bond with an electric field device, comprising the steps of:
- coupling a catalytic peptide sequence to an electrode, wherein the catalytic peptide sequence has a deprotonoated sulfhydryl group and an imidazole;
- contacting the catalytic peptide that is coupled to the electrode with a solution containing a substrate to be hydrolyzed;
- reacting the deprotonoated sulfhydryl group with the substrate to form a first intermediate;
- reacting the imidazole with the first intermediate to form a positively charged second intermediate and a negatively charged deprotonoated sulfhydryl group, wherein the positively charged second intermediate comprises an acyl bond;
- applying an electronic pulsing sequence to the electrode to separate the negatively charged deprotonoated sulfhydryl group from the positively charged second intermediate; and
- reacting the second intermediate by acyl transfer to cleave the acyl bond.
13. The method of claim 12, wherein the deprotonoated sulfhydryl group is formed from a de-protonated cysteine.
14. The method of claim 12, wherein the imidazole is part of a histidine.
15. The method of claim 12, wherein the acyl bond is an amide.
16. The method of claim 12, wherein the catalytic peptide is coupled to a permeation layer associated with the electrode.
17. The method of claim 12, wherein the step of reacting the second intermediate by acyl transfer to cleave the acyl bond comprises hydrolyzing the acyl bond.
18. The method of claim 12, wherein the substrate comprises an ester.
19. The method of claim 12, wherein the substrate comprises an amide.
20. A method for catalyzing cleavage of a bond with an electric field device, comprising the steps of:
- coupling a catalytic peptide sequence to an electrode, wherein the catalytic peptide sequence has a thiol and an imidazole;
- contacting the catalytic peptide that is coupled to the electrode with a solution containing a substrate to be hydrolyzed;
- reacting the thiol with the substrate to form a first intermediate;
- reacting the imidazole with the first intermediate to form a positively charged second intermediate and a negatively charged deprotonated thiol, wherein the positively charged second intermediate comprises an acyl bond;
- applying an electronic pulsing sequence to the electrode to separate the negatively charged deprotonated thiol from the positively charged second intermediate; and
- reacting the second intermediate by acyl transfer to cleave the acyl bond.
21. The method of claim 20, wherein the thiol is part of a cysteine.
22. The method of claim 20, wherein the imidazole is part of a histidine.
23. The method of claim 20, wherein the acyl bond is an amide.
24. The method of claim 20, wherein the catalytic peptide is coupled to a permeation layer associated with the electrode.
25. The method of claim 20, wherein the step of reacting the second intermediate by acyl transfer to cleave the acyl bond comprises hydrolyzing the acyl bond.
26. The method of claim 20, wherein the substrate comprises an ester.
27. The method of claim 20, wherein the substrate comprises an amide.
Type: Application
Filed: Dec 8, 2005
Publication Date: Mar 8, 2007
Inventor: Michael Heller (San Diego, CA)
Application Number: 11/296,927
International Classification: G06F 19/00 (20060101);